Search Results
Feb 02, 2026, 08:00 ET USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
linezolid, may be a class effect."He further stated: "While our lead DNA pol IIIC inhibitor, ibezapolstat, is Phase 3-ready for oral treatment of C. difficile Infection, and has validated the bacterial target for DNA pol IIIC inhibitors, initial studies of our new preclinical compounds show that
More news about: Acurx Pharmaceuticals, Inc.
Jan 29, 2026, 12:23 ET LYMA REPORTS STRONG 2025 PERFORMANCE WITH $48M REVENUE AS US EXPANSION DRIVES GROWTH
award-winning actresses Carey Mulligan, Kate Beckinsale, Hannah Waddingham, and top Hollywood experts and professionals Dr. Jason Diamond, Ivan Pol (The Beauty Sandwich), Pat McGrath, Joanna Czech and Dave Asprey.The LYMA Laser PRO's rapid adoption underscores the brand's innovation and
More news about: LYMA
Jan 20, 2026, 08:45 ET Digital Asset Treasury Strategy Positions Companies for Long-Term Shareholder Value
portion of the Company's existing BERA holdings not previously deployed into liquid on-chain staking.Berachain utilizes a Proof-of-Liquidity ("PoL") consensus mechanism that it describes as designed to align network security with liquidity provision and on-chain economic activity. Under this framework,
More news about: Market News Updates
Jan 15, 2026, 06:49 ET BPCL Leads Nationwide Push to Expand PNG and CNG Adoption
and LPG distributors. Its distribution network comprises over 23,500+ Fuel Stations, over 6,200+ LPG distributorships, 500+ Lubes distributorships, 80 POL storage locations, 54 LPG Bottling Plants, 79 Aviation Service Stations, 5 Lube blending plants and 5 cross-country pipelines.Bharat Petroleum
More news about: Bharat Petroleum Corporation Limited (BPCL)
Jan 08, 2026, 11:39 ET Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
partner for Syenex's best-in-class delivery platforms. In parallel, Bionova expands its off-the-shelf and custom LVV plasmid system offerings, including gag/pol, rev, VSV-G, and transgene backbones, available from RUO through GMP.This integrated approach enables rapid program initiation with off-the-shelf
More news about: Bionova Scientific
Jan 08, 2026, 07:37 ET Podczas targów elektroniki użytkowej CES 2026 NAVEE prezentuje innowacyjne rozwiązania w zakresie wysokowydajnej mobilności, rozszerzając zakres zastosowań o scenariusze outdoorowe
elektrycznego wózka golfowego z serii Birdie 3. Łączy on w sobie technologię AI Vision, UWB oraz nawigację GPS, zapewniając dostęp do ponad 40 000 map pól golfowych. Dzięki tym rozwiązaniom wózek inteligentnie omija przeszkody i automatycznie podąża za graczem, co stanowi kolejny krok w ekspansji firmy
More news about: Navee
Dec 25, 2025, 10:26 ET HTX Earn Fully Upgraded: Join HTX Earn Carnival, Earn Up to 15% APY and Apple Product Rewards
alongside a broad range of core cryptocurrencies including BTC, ETH, TRX, ZEC, TURBO, NEO, WBT, APE, COMP, QTUM, PENDLE, DOT, TON, SOL, ATOM, CSPR, POL, NEAR, ADA, SUI, APT, A, and CRV. This diverse selection is designed to accommodate both conservative yield strategies and diversified portfolio needs.The
More news about: HTX
Dec 25, 2025, 10:20 ET HTX Earn Fully Upgraded: Join HTX Earn Carnival, Earn Up to 15% APY and Apple Product Rewards
of core cryptocurrencies including BTC, ETH, TRX, ZEC, TURBO, NEO, WBT, APE, COMP, QTUM, PENDLE, DOT, TON, SOL, ATOM, CSPR, POL, NEAR, ADA, SUI, APT, A, and CRV. This diverse selection is designed to accommodate both conservative yield strategies and diversified portfolio needs.The
More news about: HTX
Dec 23, 2025, 07:00 ET Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
first-in-class small molecule with a differentiated dual mechanism of action that stabilizes DNA G-quadruplex (G4) structures while inhibiting RNA polymerase I (Pol I). This dual activity induces replication stress in tumor cells and activates the innate immune cGAS–STING pathway, effectively converting immune-cold
More news about: Senhwa Biosciences, Inc.
Dec 18, 2025, 17:30 ET Lifeway Foods Receives ISS Recommendation Supporting Company Nominees
Company, each of its independent directors (Kirk Chartier, Juan Carlos Dalto, Rachel Drori, Andee Harris, Susie Hultquist, Dorri McWhorter, Jason Scher and Pol Sikar) and certain of its executive officers (Julie Smolyansky, Chief Executive Officer, President and Secretary, and Eric Hanson, Chief Financial and
More news about: Lifeway Foods, Inc.
Dec 16, 2025, 19:06 ET Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth
four core priorities:Deepening liquidity and execution quality across the protocolExpanding protocol-owned liquidity (POL) and sustainable revenue streamsStrengthening tokenomics and aligning long-term incentives across the ecosystemSupporting partners
More news about: SushiSwap
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
establish medium-throughput assay for biochemical activity of PolC* (pol IIIC) enzymes from various Gram-positive pathogens, as well as to determine the structure of a representative PolC (pol IIIC) enzyme in complex with a novel PolC (pol IIIC) inhibitor from Acurx's portfolio. The results of this work,
More news about: Acurx Pharmaceuticals, Inc.
Nov 12, 2025, 14:43 ET DJI Agriculture prezentuje modele Agras T100, T70P i T25P na targach Agritechnica 2025 w Hanowerze
konfiguracji i umożliwia w pełni zautomatyzowaną obsługę w zakresie mapowania lotniczego i ochrony roślin. Można go na przykład zaprogramować do badania pól i sadów, wykonywania operacji śledzenia terenu na zboczu góry lub ciągłego opryskiwania lub rozsiewania na wielu blokach.
More news about: DJI
Nov 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
Israeli patent, one Japanese patent, one Indian patent, and now the Australian patent, in each case, which cover the ACX-375C program, relating to DNA Pol IIIC Inhibitors for infections caused by Gram-positive bacteria including MRSA, VRE and PRSP, with other country-level filings in process.
More news about: Acurx Pharmaceuticals, Inc.
Nov 10, 2025, 08:00 ET Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
DNA polymerase (pol) IIIC inhibitors are an innovative new class of antibiotics, the first in more than 30 years, that target a critical enzyme of Gram-positive bacteria including C. difficile, MRSA, VRE and PRSP (penicillin-resistant Streptococcus
More news about: Acurx Pharmaceuticals, Inc.
Nov 07, 2025, 20:52 ET Edward Smolyansky Issues Statement Regarding Lifeway Foods (NASDAQ: LWAY) Extension of Existing Rights Plan, Board Refreshment and Delayed 2025 Annual Meeting
was taken by a management-aligned board on the eve of a "board refreshment" and leadership deadline, with a yet to be departed director present, Mr. Pol Sikar, who continues to serve on the board at this time. It also occurred just one day before Lifeway was obligated to name a new chairperson in connection
More news about: Edward and Ludmila Smolyansky
Nov 04, 2025, 06:00 ET IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
IDE705 (GSK101), a potential first-in-class small molecule inhibitor of DNA Polymerase Theta Helicase, or Pol Theta, is being developed in collaboration with GSK. A Phase 1 dose escalation in combination with niraparib, GSK's small molecule inhibitor of PARP,
More news about: IDEAYA Biosciences, Inc.
Oct 28, 2025, 08:00 ET Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
of representative compounds from the Company's DNA pol IIIC inhibitor preclinical pipeline. In describing the work performed at his laboratory at the University of Houston, Dr. Garey stated: "Initial work on novel, lead DNA pol IIIC inhibitor compounds indicate that the positive
More news about: Acurx Pharmaceuticals, Inc.
Oct 27, 2025, 08:00 ET Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Oct 20, 2025, 17:00 ET PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project
Total cash operating costs (DAP Grande-Anse as POL) and total cash operating costs per tonne (DAP Grande-Anse as POL): Total cash operating costs (DAP Grande-Anse as POL) is a non-IFRS financial measure which includes mining, processing, site administration,
More news about: PMET Resources Inc.
Oct 09, 2025, 07:30 ET Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Threat-Level pathogen". He further stated: "While our lead DNA pol IIIC inhibitor is Phase 3-ready for oral treatment of C. difficile Infection, and has validated the bacterial target for DNA pol IIIC inhibitors, our new preclinical compounds are systemically absorbed for potential
More news about: Acurx Pharmaceuticals, Inc.
Oct 08, 2025, 08:00 ET Wells Brings Nutella Ice Cream and Kinder Bueno Frozen Dessert to U.S. Freezers
: BEL (Apr 19), CAN (Aug 20), AUS, POL, RUS, SPA, GER, SAU (Dec 20), BRA, MEX (Jan 21), ITA, TUR, UK, USA, FRA (Feb 21). ²Ipsos BVC 2024. ³socialbakers – 2018 (1st brand is Oreo) | Equity 2020 ITA GER FRA RUS GB Equity 2019 CAN BRA USA – Equity 2017 BE KSA AUS POL). Kinder Bueno
More news about: Wells Enterprises
Oct 06, 2025, 12:28 ET Huawei GOS 2025 América Latina, Impulsionando Diversas Indústrias com "Optical+AI"
os edifícios mais inteligentes. Com a crescente demanda, a tecnologia POL está se expandindo rapidamente em setores como educação, saúde e hospitalidade, atraindo cada vez mais fabricantes para o ecossistema. Acreditamos que o POL continuará crescendo, levando a IA inclusiva a milhares de campus."
More news about: HUAWEI
Oct 06, 2025, 12:26 ET Huawei GOS 2025 Latin America da inicio e impulsa un sinnúmero de industrias con tecnología «óptica + IA»
posibles edificios más inteligentes. Gracias a la creciente demanda, la tecnología de POL se expande rápidamente en sectores como la educación, la salud y la hotelería, lo que atrae a más fabricantes al ecosistema. Creemos que POL seguirá ganando terreno, impulsando miles de campus con IA inclusiva".
More news about: HUAWEI
Sep 30, 2025, 17:10 ET Lifeway and Danone Sign Cooperation Agreement
board refreshment process, Pol Sikar will step down from the Board on or before the Company's 2025 annual meeting of shareholders, and Jay Scher and another current member of the Board will step down from the Board on or before the Company's 2026 annual meeting of shareholders. Pol and Jay are the longest
More news about: Lifeway Foods, Inc.